Phaos Technology Holdings (Cayman) (POAS) Interest Expenses (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) posted Interest Expenses of $1.3 million for Q2 2025, up 55.58% on a QoQ basis from $825133.2 in Q2 2024, and up 55.58% year-over-year from $825133.2 in Q2 2024.
Phaos Technology Holdings (Cayman) (POAS) Interest Expenses (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Interest Expenses history runs 2 years deep, the most recent figure standing at $1.3 million for Q2 2025.
- Quarterly Interest Expenses rose 55.58% year-over-year to $1.3 million in Q2 2025, while the trailing twelve-month figure through Apr 2025 was $1.3 million (up 55.58% YoY) and the FY2025 annual result came in at $1.3 million, up 59.3% from the prior year.
- Interest Expenses was $1.3 million for Q2 2025 at Phaos Technology Holdings (Cayman), up from $825133.2 in the prior quarter.
- Across five years, Interest Expenses topped out at $1.3 million in Q2 2025 and bottomed at $825133.2 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -97.17 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -140.00 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 6.43 Mn | 6.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 1.28 Mn |
| Apr 30, 2025 | 1.28 Mn |
| Apr 30, 2024 | 825,133.19 |
| Apr 30, 2024 | 825,133.19 |